Syneron Medical introduces FDA-cleared 5mm spot size for treatment of onychomycosis

Syneron Candela has developed a proprietary handpiece featuring a new 5mm spot size for the Gentle Pro Nd:YAG laser series. The introduction of this new FDA-cleared handpiece expands the functionality of the GentleYAG® Pro and GentleMax® Pro Nd:YAG laser to treat onychomycosis (nail fungus) in addition to its existing capabilities for hair removal and for the treatment of vascular and pigmented lesions.

Onychomycosis is one of the most commonly diagnosed foot conditions, affecting 10-12% of the population. This prevalent and persistent disorder results in thick, jagged nails that can injure surrounding skin, spawning secondary infections and ulcers. Diabetics are especially at risk with a 34% chance of developing fungal nail infection and an increased instance of other complications. In those age 70 and up, 50% are expected to develop onychomycosis. With its precision 5mm handpiece, the Gentle Pro Nd:YAG Laser raises the temperature under the nail to a level that’s inhospitable to fungus in order to increase the appearance of clear nails, allowing physicians to treat onychomycosis symptoms locally without the systemic effects of oral medications. All infectious agents, except prions, can be killed by heat, which makes laser therapy an extremely promising new option for onychomycosis sufferers.